Is a complete SKYE research report available?

No complete published report is available for Skye Bioscience, Inc. (SKYE) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Skye Bioscience, Inc. (SKYE)

NASDAQ: SKYE · USD

$0.58

-0.03 (-5.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first SKYE analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	20.4M
Net income (ttm)	-57.3M
EPS (ttm)	-$1.45
Shares out	35.1M
Volume	205,269
Beta	2.94
Price target	$7.33	+1163.1%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -57.3M
EPS (ttm): -$1.45
Market cap: 20.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All SKYE indicators

Market & fundamental data

Available fields

185

Groups with data

Currency

USD

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001516551
Company name	Skye Bioscience, Inc.
Country	United States
Country code	US
Cusip	83086J200
Employees	2
Employees Change	-10%
Employees Change Percent	-83.33
Enterprise value	$4.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US83086J2006
Last refreshed	2026-07-31
Market cap	$20.4M
Market cap category	Nano-Cap
Price	$0.58
Price currency	USD
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2834
Symbol	SKYE
Website	https://skyebioscience.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-267.43%
FCF yield	-197.95%
P/B ratio	2.4x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-57.3M
Net Income Growth Years	0%
Profit Per Employee	$-28.7M
ROA	-87.7
Roa5y	-79.15
ROCE	-655.6
ROE	-168
ROIC	-107

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-40.96%
Cagr1y	-83.95%
Cagr3y	-55.36%
Cagr5y	-56.87%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$19.4M
Cash	$17.1M
Current Assets	$18.6M
Current Liabilities	$10.4M
Debt	$311,318
Debt Equity	$0.03
Equity	$9M
Interest Coverage	-79,087.5
Liabilities	$10.4M
Long Term Assets	$849,767
Long Term Liabilities	$0
Net Cash	$16.8M
Net Cash By Market Cap	$78.35
Net Cash Growth	-71.44%
Net Debt Equity	$-1.86
Tangible Book Value	$9M
Tangible Book Value Per Share	$0.26
WACC	20.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.78
Net Working Capital	$-8.6M
Quick ratio	1.65
Working Capital	$8.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.69%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.49%
1Y total return	-83.93%
200-day SMA	0.92
3Y total return	-91.11%
50-day SMA	0.71
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.51%
All Time High	2,750
All Time High Change	-99.98%
All Time High Date	2014-12-01
All Time Low	0.57
All Time Low Change	2.62%
All Time Low Date	2026-03-30
ATR	0.05
Beta	2.94
Beta1y	3.65
Beta2y	3.31
Ch YTD	-22.6
High	0.63
High52	4.99
High52 Date	2025-10-03
High52ch	-88.37%
Low	0.58
Low52	0.57
Low52 Date	2026-03-30
Low52ch	2.62%
Ma50ch	-18.03%
Price vs 200-day SMA	-36.72%
RSI	33.19
RSI Monthly	38.23
RSI Weekly	35.48
Sharpe ratio	-1.17x
Sortino ratio	-1.4
Total Return	-0.69%
Tr YTD	-22.6
Tr1m	-13.45%
Tr1w	-14.03%
Tr3m	-35.1%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	7
Analyst Count Top	3
Analyst Price Target Top	$11
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.27
Operating Income	$-59.1M
Price target	$7.33
Price Target Change	$1,163
Price Target Change Top	$1,796

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	22,968,417%
Float Percent	65.36%
Net Borrowing	-71,525
Shares Insiders	1.38%
Shares Institutions	11.98%
Shares Out	35,143,722
Shares Qo Q	0.02%
Shares Yo Y	0.69%
Short Float	4.59%
Short Ratio	7.71
Short Shares	3

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-49.5M
Adjusted OCF	-49,497,740
Average Volume	119,362.3x
Bv Per Share	0.26
CAPEX	$0
Ch10y	-99.49
Ch1m	-13.45
Ch1w	-14.03
Ch1y	-83.93
Ch3m	-35.1
Ch3y	-91.11
Ch5y	-98.51
Ch6m	-39.55
Change	-5.64%
Change From Open	-5.26
Close	0.62
Days Gap	-0.41
Depreciation Amortization	718,859
Dollar Volume	119,117.6
Earnings Date	2026-08-07
Earnings Time	amc
EBIT	$-59.1M
EBITDA	$-58.4M
EPS	$-1.45
F Score	1
FCF	$-42.4M
FCF EV Yield	-914.48x
FCF Per Share	$-1.21
Financing CF	-41,954
Fiscal Year End	December
Founded	2,012
Income Tax	$3,400
Investing CF	4,204,636
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-11
Last Report Date	2026-03-31
Last Split Date	2023-09-08
Last Split Type	Reverse
Last10k Filing Date	2026-03-10
Ma150	0.78
Ma150ch	-25.55%
Ma20	0.65
Ma20ch	-11.13%
Net CF	-38,272,284
Next Earnings Date	2026-08-10
Open	0.61
Optionable	Yes
Position In Range	5.66
Post Close	0.58
Postmarket Change Percent	0.53
Postmarket Price	$0.58
Ppne	813,858
Price Date	2026-07-30
Ptbv Ratio	2.38
Relative Volume	1.72x
Share Based Comp	7,062,774
Tr6m	-39.55%
Us State	California
Volume	205,269

Skye Bioscience, Inc. (SKYE)

Coverage state: Market snapshot only — no published research

Generate the first SKYE analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · SKYE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SKYE indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on SKYE

Frequently asked questions